Company patents
CONVATEC LIMITED
CONVATEC LIMITED's patent strategy reveals a surprising emerging focus on Sterilization & Biocompatible Materials, which experienced a remarkable 1000.0% year-over-year growth in 2025, despite representing only 17.6% of its portfolio. While Drug Delivery Devices remains its largest category at 58.1% of the portfolio, the significant decline in Implants & Prosthetics patenting by 30.4% so far in 2026 suggests a potential shift in priorities within its core medical device sectors.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
148 US filings (since 2023) · 4 categories · 6 themes
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Engineering and material considerations for devices used in minimally invasive procedures, focusing on mechanical properties, deployment mechanisms, and interaction with biological tissues.
Methods and apparatus for disinfecting or sterilizing medical devices, waste, or environments, often employing radiation, chemical agents, or thermal processes, and including monitoring systems.
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Materials and structures designed for implantation or tissue regeneration, focusing on properties like biodegradability, mechanical strength, cellular integration, and long-term in-vivo stability.
Patents
Showing 161-170 of 185